Adenovirus and baculovirus mediated proangiogenic gene therapy in skeletal muscle and uterine artery : safety aspects in peripheral arterial disease and fetal growth restriction therapy
Adenovirus and baculovirus mediated proangiogenic gene therapy in skeletal muscle and uterine artery : safety aspects in peripheral arterial disease and fetal growth restriction therapy
Adenovirus and baculovirus mediated proangiogenic gene therapy in skeletal muscle and uterine artery : safety aspects in peripheral arterial disease and fetal growth restriction therapy
Adenovirus and baculovirus mediated proangiogenic gene therapy in skeletal muscle and uterine artery : safety aspects in peripheral arterial disease and fetal growth restriction therapy
Adenovirus and baculovirus mediated proangiogenic gene therapy in skeletal muscle and uterine artery : safety aspects in peripheral arterial disease and fetal growth restriction therapy
Adenovirus and baculovirus mediated proangiogenic gene therapy in skeletal muscle and uterine artery : safety aspects in peripheral arterial disease and fetal growth restriction therapy
Adenovirus and baculovirus mediated proangiogenic gene therapy in skeletal muscle and uterine artery : safety aspects in peripheral arterial disease and fetal growth restriction therapy
Artikkeliväitöskirjan yhteenveto-osa ja 3 eripainosta.
kuvitettu, taulukkoja
Nimiösivulla myös: Department of Biotechnology and Molecular Medicine, A.I.Virtanen Institute for Molecular Sciences, Faculty of Health Sciences, University of Eastern Finland, Kuopio 2013.
Adenovirus and baculovirus mediated proangiogenic gene therapy in skeletal muscle and uterine artery : safety aspects in peripheral arterial disease and fetal growth restriction therapy
